Your SlideShare is downloading. ×
9..hemodynamic disorders
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

9..hemodynamic disorders

279

Published on

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
279
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
16
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Hemodynamic Disorders
  • 2. Hemodynamics  Hemodynamics, meaning literally "blood movement" is the study of blood flow or the circulation.  It explains the physical laws that govern the flow of blood in the blood vessels.
  • 3.  The health of cells and tissues depends not only on an intact circulation to deliver oxygen and remove wastes but also on normal fluid homeostasis.  Normal fluid homeostasis requires vessel wall integrity as well as maintenance of intravascular pressure and osmolarity within certain physiologic ranges.
  • 4.  Increases in vascular volume or pressure, decreases in plasma protein content, or alterations in endothelial function can result in a net outward movement of water across the vascular wall.  Such water extravasation into interstitial spaces is called edema; depending on its location, edema may have minimal or profound effects.  Thus, in the lower extremities edema fluid causes primarily swelling; however, in the lungs, edema fluid will fill alveoli and can result in life-threatening breathing difficulties.
  • 5.  Normal fluid homeostasis also means maintaining blood as a liquid until such time as injury necessitates formation of a clot.  Absence of clotting after vascular injury results in hemorrhage; local bleeding can compromise regional tissue perfusion, while more extensive hemorrhage can result in hypotension (shock) and death.  Conversely, inappropriate clotting (thrombosis) or migration of clots (embolism) can obstruct tissue blood supplies and cause cell death (infarction).  Abnormal fluid homeostasis (i.e., hemorrhage or thrombosis) underlies three of the most important causes of morbidity and mortality in Western society: myocardial infarction, pulmonary embolism, and cerebrovascular accident (stroke).
  • 6. Hemodynamic Disorders EDEMA  Approximately 60% of lean body weight is water, two-thirds of which is intracellular and the remainder is in extracellular compartments, mostly as interstitial fluid; only 5% of total body water is in blood plasma.  The term edema signifies increased fluid in the interstitial tissue spaces.  Fluid collections in different body cavities are variously designated hydrothorax, hydropericardium, or hydroperitoneum.
  • 7.  Anasarca is a severe and generalized edema with profound subcutaneous tissue swelling.  The mechanism of inflammatory edema mostly involves increased vascular permeability.
  • 8. Causes of Edema  Two types :  Non inflammatory - Increased hydrostatic pressure - Decreased plasma osmotic pressure - Lymphatic obstruction.  Inflammatory - During the process of inflammation.
  • 9. Increased Hydrostatic Pressure          Impaired venous return. Congestive heart failure. Constrictive pericarditis. Ascites (liver cirrhosis). Venous obstruction or compression. Thrombosis. External pressure (e.g. tumor, mass) Lower extremity inactivity with prolonged dependency Arteriolar dilation.
  • 10. Reduced Plasma Osmotic Pressure - The serum protein is most responsible for mainatinig colloid osmotic pressure.  Protein-losing glomerulopathies (NS)  Liver cirrhosis (ascites)  Malnutrition.  Protein-losing gastroenteropathy.
  • 11.  Lymphatic Obstruction      Sodium Retention      Inflammatory ( Filariasis) Neoplastic Postsurgical. Postirradiation. Excessive salt intake with renal insufficiency Increased tubular reabsorption of sodium Renal hypoperfusion Increased renin-angiotensin-aldosterone secretion Inflammation   Acute inflammation Chronic inflammation
  • 12. Clinical Correlation  The effects of edema may range from merely annoying to rapidly fatal.  Subcutaneous edema in cardiac or renal failure is important primarily because it indicates underlying disease.  In contrast, pulmonary edema can cause death by interfering with normal ventilatory function and also creates a favorable environment for bacterial infection.
  • 13.  Brain edema is serious and can be rapidly fatal.  If severe, brain edema can cause Herniation (extrusion of the brain) through the foramen magnum.  The brainstem vascular supply can also be compressed by edema causing increased intracranial pressure.
  • 14. HYPEREMIA AND CONGESTION  Both indicate a local increased volume of blood in a particular tissue.  Hyperemia is an active process resulting from augmented blood flow due to arteriolar dilation (e.g., at sites of inflammation or in skeletal muscle during exercise).  The affected tissue is redder than normal because of engorgement with oxygenated blood.
  • 15. CONGESTION  Congestion is a passive process resulting from impaired venous return out of a tissue.  It may occur systemically, as in cardiac failure, or it may be local, resulting from an isolated venous obstruction.  The tissue has a blue-red color (cyanosis), especially as worsening congestion leads to accumulation of deoxygenated hemoglobin in the affected tissues
  • 16.  Congestion of capillary beds is closely related to the development of edema, so that congestion and edema commonly occur together.  In long-standing congestion, called chronic passive congestion, the stasis of poorly oxygenated blood causes chronic hypoxia, which in turn can result in degeneration or death of parenchymal cells and subsequent tissue fibrosis.  Capillary rupture at such sites of chronic congestion can also cause small foci of hemorrhage; phagocytosis and catabolism of the erythrocyte debris can result in accumulations of hemosiderin-laden macrophages.
  • 17. Morphology  Cut surfaces of hyperemic or congested tissues are hemorrhagic and wet.  Microscopically, acute pulmonary congestion is characterized by alveolar capillaries engorged with blood; there may also be associated alveolar septal edema and/or focal minute intra-alveolar hemorrhage.  In chronic pulmonary congestion the septa become thickened and fibrotic, and the alveolar spaces may contain numerous hemosiderin-laden macrophages .
  • 18.  In acute hepatic congestion the central vein and sinusoids are distended with blood.  There may even be central hepatocyte degeneration.  The periportal hepatocytes, better oxygenated because of their proximity to hepatic arterioles, undergo less severe hypoxia and may develop only fatty change.
  • 19.  In chronic passive congestion of the liver the central regions of the hepatic lobules are grossly red-brown and slightly depressed (because of a loss of cells) "nutmeg liver.
  • 20. Liver with chronic passive congestion & hemorrhagic necrosis . A, Central areas are red and slightly depressed compared with the surrounding tan viable parenchyma, forming a "nutmeg liver" pattern (so called because it resembles the alternating pattern of light and dark seen when a whole nutmeg is cut). B, Centrilobular necrosis with degenerating hepatocytes and hemorrhage
  • 21. HEMORRHAGE  Hemorrhage is extravasation of blood from vessels into the extravascular space.  Capillary bleeding can occur under conditions of chronic congestion; an increased tendency to hemorrhage (usually with insignificant injury) occurs in a wide variety of clinical disorders collectively called hemorrhagic diseases.  Rupture of a large artery or vein results in severe hemorrhage, and is almost always due to vascular injury, including trauma, atherosclerosis, or inflammatory or neoplastic erosion of the vessel wall.
  • 22.  Hemorrhage can be external or can be confined within a tissue; any accumulation is referred to as a hematoma.  Hematomas can be relatively insignificant (e.g., a bruise) or can involve so much bleeding as to cause death (e.g. a massive subarachnoid hematoma resulting death.)
  • 23. Types of Hemorrhage  Minute (1- to 2-mm) hemorrhages into skin, mucous membranes, or serosal surfaces are called petechiae and are typically associated with locally increased intravascular pressure, low platelet counts (thrombocytopenia), defective platelet function, or clotting factor deficiencies  Slightly larger (3- to 5-mm) hemorrhages are called purpura and can be associated with many of the same disorders that cause petechiae; in addition, purpura can occur with trauma, vascular inflammation (vasculitis)
  • 24.  Larger (1- to 2-cm) subcutaneous hematomas (bruises) are called ecchymoses.  Large accumulations of blood in one or another of the body cavities are called hemothorax, hemopericardium, hemoperitoneum, or hemarthrosis (in joints).  Patients with extensive hemorrhages occasionally develop jaundice from the massive breakdown of red blood cells and systemic increases in bilirubin.
  • 25. Clinical Significance  Depends on the volume and rate of blood loss.  Rapid removal of around 20% of blood volume or slow losses of even larger amounts may have little impact in healthy adults;  Greater losses, however, can cause hypovolemic shock.  The site of hemorrhage is also important; bleeding that would be trivial in the subcutaneous tissues may cause death if located in the brain.  Finally, chronic or recurrent external blood loss (e.g., a peptic ulcer or menstrual bleeding) causes a net loss of iron, leading to iron deficiency anemia.  In contrast, when red cells are retained (e.g., with hemorrhage into body cavities or tissues), the iron can be reutilized for hemoglobin synthesis.
  • 26. A, Punctate petechial hemorrhages of the colonic mucosa, a consequence of thrombocytopenia. B, Fatal intracerebral hemorrhage.
  • 27. HEMOSTASIS AND THROMBOSIS  Normal hemostasis is a consequence of tightly regulated processes that maintain blood in a fluid, clot-free state in normal vessels while inducing the rapid formation of a localized hemostatic plug at the site of vascular injury.  The pathologic form of hemostasis is thrombosis; it involves blood clot (thrombus) formation in uninjured CVS or thrombotic occlusion of a vessel after relatively minor injury.  Both hemostasis and thrombosis involve three components: the vascular wall, platelets, and the coagulation cascade.
  • 28. Thrombosis  There are three primary influences on thrombus formation (called Virchow's triad):    (1) endothelial injury, (Alteration in wall) (2) stasis or turbulence of blood flow (Alteration in flow) (3) blood hypercoagulability (Alteration in cougulability)
  • 29. Endothelial Injury  This is a dominant influence, since endothelial loss by itself can lead to thrombosis.  It is particularly important for thrombus formation occurring in the heart or in the arterial circulation, where the normally high flow rates might otherwise hamper clotting by preventing platelet adhesion or diluting coagulation factors.  Thus, thrombus formation within the cardiac chambers (e.g., after endocardial injury due to myocardial infarction), over ulcerated plaques in atherosclerotic arteries, or at sites of traumatic or inflammatory vascular injury (vasculitis) is largely a function of endothelial injury.
  • 30. Endothelial Injury….  Clearly, physical loss of endothelium leads to exposure of subendothelial ECM, adhesion of platelets, release of tissue factor, and local depletion of PGI2 and plasminogen activators.  However, endothelium need not be denuded or physically disrupted for thrombosis; any imbalance between prothrombotic and antithrombotic activities of endothelium can influence local clotting events
  • 31.  Significant endothelial dysfunction (in the absence of endothelial cell loss) may occur with hypertension, turbulent flow over scarred valves, or by the action of bacterial endotoxins.  Even relatively subtle influences, such as hypercholesterolemia, radiation, or products absorbed from cigarette smoke, may be sources of endothelial dysfunction
  • 32. Alterations in Normal Blood Flow  Turbulence contributes to arterial and cardiac thrombosis by causing endothelial injury or dysfunction, as well as by forming countercurrents and local pockets of stasis; stasis is a major contributor to the development of venous thrombi.
  • 33.  Normal blood flow is laminar, such that platelets flow centrally in the vessel lumen, separated from the endothelium by a slower moving clear zone of plasma. Stasis and turbulence therefore:  Disrupt laminar flow and bring platelets into contact with the endothelium  Retard the inflow of clotting factor inhibitors and permit the buildup of thrombi  Promote endothelial cell activation, resulting in local thrombosis, leukocyte adhesion, etc.
  • 34. Hypercoagulability  Generally contributes less frequently to thrombotic .  It is loosely defined as any alteration of the coagulation pathways that predisposes to thrombosis, and it can be divided into primary (genetic) and secondary (acquired) disorders .  Of the inherited causes mutations in the factor V gene and the prothrombin gene are the most common:
  • 35. Acquired thrombotic diatheses: multifactorial and complicated  In some situations (e.g., cardiac failure or trauma), stasis or vascular injury may be most important.  Hypercoagulability due to use of oral contraceptive use and hyperestrogenic state of pregnancy, related to increased hepatic synthesis of coagulation factors and reduced synthesis of antithrombin III.
  • 36.  In disseminated cancers, release of procoagulant tumor products predisposes to thrombosis.  Hypercoagulability in advancing age has been attributed to increasing platelet aggregation and reduced endothelial PGI2 release.  Smoking and obesity promote hypercoagulability by unknown mechanisms
  • 37. Hypercougulability
  • 38. Morphology  Thrombi can develop anywhere in the cardiovascular system (in cardiac chambers, on valves, in arteries, veins, capillaries).  The size and shape of a thrombus depend on the site of origin and the cause.  Arterial or cardiac thrombi begin at sites of endothelial injury or turbulence; venous thrombi occur at sites of stasis.  Thrombi are focally attached to the underlying vascular surface.
  • 39.  Arterial thrombi tend to grow in a retrograde direction from the point of attachment,  Venous thrombi extend in the direction of blood flow (thus both tend to propagate toward the heart).  The propagating portion of a thrombus is poorly attached and therefore prone to fragmentation, generating an embolus.
  • 40. Morphology  Thrombi can have grossly (and microscopically) apparent laminations called lines of Zahn; these represent pale platelet and fibrin layers alternating with darker erythrocyte-rich layers.  Such lines are significant only in that they represent thrombosis in the setting of flowing blood; their presence can therefore potentially distinguish antemortem thrombosis from the bland nonlaminated postmortem clots  Thrombi occurring in heart chambers or in the aortic lumen are designated mural thrombi.
  • 41. Morphology  Arterial thrombi are frequently occlusive and are produced by platelet and coagulation activation; they are typically a friable meshwork of platelets, fibrin, erythrocytes, and degenerating leukocytes.  Venous thrombosis (phlebothrombosis) is almost invariably occlusive, venous thrombosis is largely the result of activation of the coagulation cascade, and platelets play a secondary role.  Because these thrombi form in the sluggish venous circulation, they also tend to contain more enmeshed erythrocytes and are therefore called red, or stasis, thrombi.
  • 42. Specific types of Thrombi  Thrombi on heart valves are called vegetations.  Bacterial or fungal blood-borne infections can cause valve damage, subsequently leading to large thrombotic masses (infective endocarditis,).  Sterile vegetations can also develop on noninfected valves in hypercoagulable states, so-called nonbacterial thrombotic endocarditis
  • 43. Fate of the Thrombus  Propagation: accumulation of additional platelets and fibrin, eventually causing vessel obstruction.  Embolization: Thrombi dislodge or fragment and are transported elsewhere in the vasculature.  Dissolution: Thrombi are removed by fibrinolytic activity.  Organization and recanalization.  Thrombi induce inflammation and fibrosis (organization). These can eventually recanalize (re-establishing some degree of flow), or they can be incorporated into a thickened vessel wall
  • 44. Low-power view of an artery with an old thrombus. A, H&E-stained section. B, Stain for elastic tissue. The original lumen is delineated by the internal elastic lamina (arrows) and is totally filled with organized thrombus, now punctuated by a number of recanalized channels (white spaces).
  • 45. EMBOLISM  An embolus is a intravascular solid, liquid, or gaseous mass that is carried by the blood to a site distant from its point of origin (Formation or entry).  Virtually 99% of all emboli represent some part of a dislodged thrombus, hence the term thromboembolism.  Rare forms of emboli include fat droplets, bubbles of air , atherosclerotic debris (cholesterol emboli), tumor fragments, bits of bone marrow, or foreign bodies such as bullets.
  • 46. EMBOLISM  However, unless otherwise specified, an embolism should be considered to be thrombotic in origin.  Inevitably, emboli lodge in vessels too small to permit further passage, resulting in partial or complete vascular occlusion.  The consequences of thromboembolism include ischemic necrosis (infarction) of downstream tissue.  Depending on the site of origin, emboli may lodge anywhere in the vascular tree; the clinical outcomes are best understood from the standpoint of whether emboli lodge in the pulmonary or systemic circulations
  • 47. Embolus derived from a lower extremity deep venous thrombosis and now impacted in a pulmonary artery branch
  • 48. Pulmonary Embolism  They are carried through progressively larger channels and pass through the right side of the heart before entering the pulmonary vasculature.  Depending on the size of the embolus, it may occlude the main pulmonary artery, impact across bifurcation (saddle embolus), or pass out into the smaller, branching arterioles.  Frequently, there are multiple emboli, perhaps sequentially, or as a shower of smaller emboli from a single large thrombus; in general, the patient who has had one pulmonary embolus is at high risk of having more.  Rarely, an embolus can pass through an interatrial or interventricular defect, thereby entering the systemic circulation (paradoxical embolism).
  • 49. Pulmonary Embolism  Sudden death, right ventricular failure (cor pulmonale), or cardiovascular collapse occurs when 60% or more of the pulmonary circulation is obstructed with emboli.  Embolic obstruction of medium-sized arteries can cause pulmonary hemorrhage but usually not pulmonary infarction because the lung has a dual blood supply and the intact bronchial arterial circulation continues to supply blood to the area  Many emboli occurring over a period of time may cause pulmonary hypertension with right ventricular failure.
  • 50. Systemic Thromboembolism  Systemic thromboembolism refers to emboli in the arterial circulation.  Most (80%) arise from intracardiac mural thrombi, two-thirds of which are associated with left ventricular wall infarcts and another quarter with dilated left atria (e.g., secondary to mitral valve disease).  The remainder originate from aortic aneurysms, thrombi on ulcerated atherosclerotic plaques, or fragmentation of valvular vegetations Arterial emboli can travel to a wide variety of sites; the site of arrest depends on the point of origin of the thromboembolus and the relative blood flow through the downstream tissues.   The major sites for arteriolar embolization are the lower extremities (75%) and the brain (10%), with the intestines, kidneys, and spleen affected to a lesser extent

×